5 Einträge gefunden

1. Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations

   1. Pollyea, Daniel A
   2. DiNardo, Courtney D
   3. Arellano, Martha L
   4. Pigneux, Arnaud
   5. Fiedler, Walter
   6. Konopleva, Marina
   7. Rizzieri, David A

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

   1. Heuser, Michael
   2. Smith, B Douglas
   3. Fiedler, Walter
   4. Sekeres, Mikkael A
   5. Montesinos, Pau
   6. Leber, Brian
   7. Merchant, Akil

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

   1. Heuser, Michael
   2. Smith, B Douglas
   3. Fiedler, Walter
   4. Sekeres, Mikkael A
   5. Montesinos, Pau
   6. Leber, Brian
   7. Merchant, Akil

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

   1. Cortes, Jorge E
   2. Heidel, Florian H
   3. Fiedler, Walter
   4. Smith, B Douglas
   5. Robak, Tadeusz
   6. Montesinos, Pau
   7. Candoni, Anna

   2020 - Forschungsinformationssystem des UKE
5. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

   1. Cortes, Jorge E
   2. Heidel, Florian H
   3. Hellmann, Andrzej
   4. Fiedler, Walter
   5. Smith, B Douglas
   6. Robak, Tadeusz
   7. Montesinos, Pau

   2019 - Forschungsinformationssystem des UKE